Apr 9, 2013, 06:00 by Michael Croft

eCliniqua | The keynote session at the inaugural Medical Informatics World Conference in Boston yesterday kicked off conversations on a broad range of health-IT challenges: everything from Meaningful Use Stage 2 to the coming surge of clinical genomics.

Apr 8, 2013, 09:00 by Michael Croft

eWeek | HP Enterprise Services UK signed a 10-year, $210 million contract with Cambridge University Hospitals NHS Foundation Trust in Bracknell, United Kingdom.

Apr 3, 2013, 08:00 by Michael Croft

eCliniqua News Brief | Insight Genetics has been selected by the National Cancer Institute (NCI) to participate in the Clinical Assay Development Program (CADP), an initiative of NCI’s Division of Cancer Treatment and Diagnosis that aims to move promising assays from the research lab into clinical trials.

Apr 2, 2013, 08:00 by Michael Croft

eCliniqua News Brief | Last week, MyClinicalTrialLocator.com, a global clinical trials aggregator site launched that gives patients access to trials around the world from their mobile device. The site uses publicly available information from clinicaltrials.gov, as well as information from academic medical centers to create an easier and more accessible website for patients, parents and caregivers.

Mar 29, 2013, 13:00 by Michael Croft

eCliniqua Brief | A study found that using EHR data to recruit for clinical trials did not work as well as hoped. A group in Germany assessed EHR data from five German university hospitals for data completeness. The group looked to see whether EHR data was complete enough to use for clinical trial recruitment.

Mar 26, 2013, 10:00 by Michael Croft

eCliniqua | When clinical trial sponsors reach out to sites, they may use a newsletter or rely on word-of-mouth messages passed from the project team to regional managers to sites. The result is like the children’s game, Telephone. Everyone gets a slightly different version of old news. PHT Corporation aims to fix that with MyStudyHome, an online social community to connect clinical trial sponsors with sites.

Mar 22, 2013, 10:00 by Michael Croft

eCliniqua News Brief | ePharmaSolutions, CenterWatch, and a consortium of pharmaceutical companies and contract research organizations have launched the 'Referral Plus' Initiative to increase opportunities for patients to find trials for which they may qualify.

Mar 21, 2013, 13:00 by Michael Croft

In the Pipeline | Why post-trial data analysis is so important: Derek Lowe looks at the case study of one company that rushed their positive Phase III trial results.

Mar 15, 2013, 13:00 by Michael Croft

Huffington Post | The clinical trial experience affects a wide range of stakeholders, including patients' caregivers.

Mar 14, 2013, 13:00 by Michael Croft

eCliniqua Product Brief | ArisGlobal has launched agSupply, an integrated IWRS (Interactive Web Response System) and logistics management system that automates the tracking of clinical trial supplies throughout the supply chain.

Mar 13, 2013, 14:00 by Michael Croft

eCliniqua | Alliance for Clinical Research Excellence and Safety (ACRES) has named co-chairs for its Site Accreditation Standards Initiative (SASI). Inaugurated in December of 2012, SASI brings together prominent representatives from the multi-sector biomedical research community to promote formal standards for accreditation of clinical research sites worldwide. Linda Meyerson and Tracy Blumenfeld who will serve as Co-Chairs of the SASI Steering Committee.

Mar 8, 2013, 10:00 by Michael Croft

New York Times | Using Google, Yahoo, and Microsoft seach histories, researchers have discovered prescription drug side effects before FDA.

Mar 6, 2013, 08:00 by Michael Croft

C-SPAN | Ben Goldacre talks about his book, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients. He discusses the influence of the pharmaceutical industry on the global health care system and argues that pharmaceutical companies hide negative studies and use questionable testing and intensive lobbying to get what they want, regardless of whether the drugs they produce are good for patients.

Mar 4, 2013, 11:00 by Michael Croft

News Brief |  GNS Healthcare has joined in the formation of Orion Bionetworks, a new alliance to accelerate the drug development process for a wide variety of diseases, beginning with multiple sclerosis (MS). Using patient data from alliance members Accelerated Cure Project for Multiple Sclerosis, the Institute for Neurosciences at Brigham and Women’s Hospital, and PatientsLikeMe, GNS will build powerful, predictive, computational models to yield new information about the disease.

Mar 4, 2013, 09:00 by Michael Croft

eClin Roundup | Federal cost cutting measures should look no farther than the FDA, argues an op ed in Bloomberg. First on the chopping block: Phase 3 clinical trials. But would that actually work?

Feb 25, 2013, 09:00 by Michael Croft

Bio-IT World | Thanks to a $1.9 million grant from the Robert Wood Johnson Foundation, PatientsLikeMe will lead development of truly “patient-centered” health outcome measures via the world’s first open-participation research platform. Never before have crowdsourcing approaches to authoring, reviewing, and validating outcome measures been attempted on a single system, says Jamie Heywood.

Feb 18, 2013, 07:00 by Michael Croft

eCliniqua | Contributed Commentary | In recent years, clinical sponsors have struggled to streamline their clinical operations. Studies have grown increasingly complex with the inclusion of more procedures and eligibility criteria than ever before. The volume of data being collected for trials has increased and enrollment has become more difficult. However, sponsors’ return on investment remains unclear despite the acceptance of increased risk and efforts.

Feb 12, 2013, 15:00 by Michael Croft

eCliniqua News Brief | JLL Partners, a private equity firm, announced yesterday that two of its subsidiaries have commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share in cash. A successful offer will result in a merger between BioClinica and BioCore Holdings, one of the subsidiaries.

Feb 7, 2013, 13:00 by Michael Croft

News Brief | Yesterday Oracle announced the first upgrade to the ClearTrial product since it acquired the company in May 2012. The newest version of Oracle Health Sciences ClearTrial Plan and Source Cloud Service will deliver enhanced planning, sourcing, and tracking capabilities to support Phase I trials and complex multi-arm studies.

Feb 4, 2013, 09:00 by Michael Croft

SF Gate | Icon plans to buy the clinical trial services division of Cross Country Healthcare for $52 million in cash and another $3.75 million in potential milestone payments. Icon provides development services to drug and medical device makers.